ClinicalTrials.gg
RecruitingNCT05288140QUADERNUpdated Mar 27, 2024

Efficacy of the Use of Diaries in Intensive Care Units

An interventional study of use of diary in Diary (Blank Journal), Intensive Care Unit and Patient, sponsored by University of Barcelona. Recruiting at 1 site in Spain. Open to participants aged 18 Years to 100 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2024-03-27.

Primary conditionDepressionRegistry: Anxiety DisordersReclassifiedWhy we changed it
Registry
Anxiety Disorders — the first condition term the registry derived for this study.
ClinicalTrials.gg
Depression
Why
  1. The registry often attaches Anxiety Disorders to studies about something else, and this study's title and listed conditions do not name it.
  2. The study's listed conditions name Depression.
Confidence
High: the new condition is named in the study's own listed conditions. Of 351 hand-checked studies reclassified this way, 68% were exactly right and 84% in the right disease family; the registry's first term was right for 5% (measured 2026-10-21). How we classify →
Wrong?
Tell us the study's main condition →

Sponsored by University of Barcelona · Not applicable, Interventional, and Prevention

How we know

From the registry’s dates

  • Primary completion was expected by Dec 2025, 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2022; still recruiting 4 years 10 months later.

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
240
Allocation
Randomized
Ages
18 Years to 100 Years
Sex
All
01

Where this study stands

Counted across the records on this site · 2026-11-21

Among 225 studies in Depression with a site in Spain — 46 open to participants now, 58 under way, 7 of them phase 3. Depression · Spain.

Planned enrollment
48th of 189
240 · median 123
Started
2022
with 14 others
No phase
153 of 225
35 open now
Primary completion
2025-12
later than 18 of 57 live
Registered
144th of 225
by date
Lead sponsor
6 of 225
University of Barcelona

Among the 225 studies in Depression with a site in Spain, this one is the 48th largest by planned enrollment of the 189 interventional ones that give a count, is one of 15 that started in 2022, is one of 153 with no phase, reaches primary completion later than 18 of the 57 other live ones, and was the 144th registered.

Depression

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

Browse Depression studies →

Open to participants now

46 of the 225 studies in Depression with a site in Spain are open now. Recruiting first, the newest first:

41 more — sign in →

All 46 open studies →

A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →

Who these studies take

Of the 1,098 Depression studies recruiting now, 475 (43%) set no upper age limit and 522 (48%) stop at 75 or younger; 205 take children under 18; 315 take healthy volunteers.

This study: 18 Years to 100 Years · all sexes · healthy volunteers too.

The full table on the hub →

This tab as a report to print or save as PDF → With an account.

Was this useful?
Get alerts for this landscapeDownload CSVNarrow it in search →With an account: a weekly mail of what changed among 225 studies in Depression with a site in Spain, or all of them as a file.
02

Study summary

Randomized clinical trial that aims to evaluate the impact of the use of a diary in patients and relatives of patients admitted to an ICU in relation to usual practice in terms of health-related quality of life, the post-traumatic stress and anxiety/depression at 2, 6 and 12 months after ICU discharge.

Read the detailed description

Randomized, parallel, open, non-blinded, multicenter clinical trial, with an experimental group (diary) and a control group (usual practice), to compare the effect produced on quality of life by post-traumatic stress and anxiety/depression of patients and relatives, whether or not they have access to a diary during the stay in the unit. Three validated scales will be used at three different times. 120 cases per group, carrying out a preliminary pilot test. Data analysis according to IBM SPSS v.24 to describe and compare both groups.

03

Conditions studied

  • Diary (Blank Journal)
  • Intensive Care Unit
  • Patient
  • Family
  • PICS
  • Stress
  • Anxiety
  • Depression
  • Quality of Life

Browse trials for

04

In context

Depression Reclassified

8,608 studies on the registry are indexed under Depression; 1,736 are open to participants now.

This study's planned enrollment of 240 is above the median of 81 across 7,089 interventional studies indexed under Depression.

Browse Depression studies →

Lead sponsor

University of Barcelona is the lead sponsor of 100 studies on the registry; 30 are open to participants now.

Compared within Depression, this study's primary condition as ClinicalTrials.gg classifies it; the registry's first condition term is Anxiety Disorders. The counts are of registry records indexed under each term, refreshed daily. How we classify →

05

Who can participate

Ages eligible
18 Years to 100 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • admitted intensive care unit
  • sedated and mechanically ventilated for 24hours
  • signed consent
  • not language barrier
  • willingness to attend follow-up visits

Exclusion criteria

Exclusion Criteria:

  • verbal manifestation of psychiatric, mental or cognitive antecedents
  • who do not coluntarily agree to participate
06

Study design

Phase
Not applicable
Primary purpose
Prevention
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Triple (Participant, Care provider, Investigator)
Enrollment
240 participants (estimated)

Study arms

  • No intervention
    usual ICU practice

    The patient's evolution is reported verbally to the family.

  • Experimental
    ICU diary

    Made a diary

    Other: use of diary

Interventions

  • Otheruse of diary

    a diary is made for the experimental group where the events and events during the period of sedation and intubation are explained

07

What researchers measure

Primary outcomes

  1. Hospital Anxiety and Depression Scale (HADS)

    questionnaries, range of 0-21 for either anxiety and depression subscores. Higher scores corresponding to worse outcomes. 0-7 normal; 8-10 borderline abnormal; 11-21 sever symptoms of anxiety or depressin.

    Time frame: 2 months

  2. Hospital Anxiety and Depression Scale (HADS)

    questionnaries, range of 0-21 for either anxiety and depression subscores. Higher scores corresponding to worse outcomes. 0-7 normal; 8-10 borderline abnormal; 11-21 sever symptoms of anxiety or depressin.

    Time frame: 6 months

  3. Hospital Anxiety and Depression Scale (HADS)

    questionnaries, range of 0-21 for either anxiety and depression subscores. Higher scores corresponding to worse outcomes. 0-7 normal; 8-10 borderline abnormal; 11-21 sever symptoms of anxiety or depressin.

    Time frame: 12 months

  4. SF-36 Health Survey

    questionnaries to measure quality of life. 36 items. from 0 to 100, with 100 being the best health

    Time frame: 2 months

  5. SF-36 Health Survey

    questionnaries to measure quality of life. 36 items. from 0 to 100, with 100 being the best health

    Time frame: 6 months

  6. SF-36 Health Survey

    questionnaries to measure quality of life. 36 items. from 0 to 100, with 100 being the best health

    Time frame: 12 months

  7. Revised Impact of Event Scales (IES-R)

    questionnaries; measuring areas of hyperarousal, avoidance, and intrusion as subscales. Total score ranges from 0-88, higher score associated with worse PTSD symptoms. 1-22 mild PTSD,;22 signal clinically significant PTSD symptoms.

    Time frame: 2 months

  8. Revised Impact of Event Scales (IES-R)

    questionnaries; measuring areas of hyperarousal, avoidance, and intrusion as subscales. Total score ranges from 0-88, higher score associated with worse PTSD symptoms. 1-22 mild PTSD,;22 signal clinically significant PTSD symptoms.

    Time frame: 6 months

  9. Revised Impact of Event Scales (IES-R)

    questionnaries; measuring areas of hyperarousal, avoidance, and intrusion as subscales. Total score ranges from 0-88, higher score associated with worse PTSD symptoms. 1-22 mild PTSD,;22 signal clinically significant PTSD symptoms.

    Time frame: 12 months

08

Study locations

1 of 1 sites recruiting
  • Universidad de Barcelona
    Barcelona, 08185, Spain
    Recruiting
09

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

10

Timeline

Tracking since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Jan 2022 (actual). Primary completion is estimated for Dec 2025, 47 months after the start.

Of 3,486 non-industry interventional studies with no phase under Depression, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 41. This study's planned 47 months is above that.

Counting every sponsor, half of 3,584 studies reached it within 21 months; a quarter within 9 and three quarters within 41.

How these figures are worked out, and which studies are left out of them.

Registered
Feb 1, 2022
First posted
Mar 21, 2022
StartActual
Jan 1, 2022
Primary completionEst.
Dec 31, 2025
CompletionEst.
Dec 31, 2026
Last update
Mar 27, 2024
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
No changes since tracking began. The registry record was last updated on Mar 27, 2024, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
11

Registry details

Key details

Study ID
NCT05288140
Responsible party
Pilar Muñoz Rey (principal investigator, University of Barcelona) — Principal investigator
First posted
Mar 21, 2022
Start date
Jan 1, 2022
Primary completion
Dec 31, 2025 (estimated)
Completion
Dec 31, 2026 (estimated)
Last update
Mar 27, 2024

Study contacts

Pilar Muñoz Rey
Contact
mpmunozr.germanstrias@gencat.cat
639534904

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion